• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PC1
Click for more information
9.09% 1.0¢

PLUS CONNECT LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
PC1 Non-Renounceable Issue - Offer DocumentPRICE SENSITIVE27/08/10
PC1 Non-Renounceable Issue - s708AA Notice27/08/10
PC1 Non-Renounceable Issue - Shareholder letter27/08/10
PC1 Non-Renounceable Issue - Appendix 3B27/08/10
PC1 s708A NoticePRICE SENSITIVE23/08/10
PC1 Appendix 3B23/08/10
PC1 Hawaii Biotech Inc UpdatePRICE SENSITIVE23/07/10
PC1 Appointment of broker for capital raising19/07/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE08/07/10
PC1 Business Update - HBI and Proposed Capital RaisingPRICE SENSITIVE30/06/10
PC1 Change in substantial holding17/06/10
PC1 Change in substantial holding09/06/10
PC1 Change of Director's Interest Notice08/06/10
PC1 Non Renounceable Rights Issue - Allotment04/06/10
PC1 Non Renounceable Rights Issue Result28/05/10
PC1 Rights issue dispatch confirmation13/05/10
PC1 Non Renounceable Rights Issue - Offer Letter04/05/10
PC1 Non Renounceable Rights Issue - Appendix 3B04/05/10
PC1 Non-Renounceable Rights Issue - shareholder letterPRICE SENSITIVE04/05/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/04/10
PC1 Change of Director's Interest Notice x 225/03/10
PC1 Appendix 3B25/03/10
PC1 Acuvax Undertakes Share PlacementPRICE SENSITIVE23/03/10
PC1 Appendix 4D and Half Year AccountsPRICE SENSITIVE26/02/10
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/01/10
PC1 HBI Completes Phase 1 TrialPRICE SENSITIVE11/01/10
PC1 Acuvax Affliate Receives Capital InjectionPRICE SENSITIVE22/12/09
PC1 Acuvax Affiliate ReorganisesPRICE SENSITIVE14/12/09
PC1 Results of Meeting30/11/09
PC1 CEO's AGM Presentation30/11/09
PC1 Chairman's Address to Shareholders30/11/09
PC1 Initial Director's Interest Notice27/11/09
PC1 Director Appointment/Resignation23/11/09
PC1 Company Secretary Appointment/Resignation10/11/09
PC1 Acuvax Requisitions Meeting of HBI Shareholders09/11/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE30/10/09
PC1 Notice of Annual General Meeting/Proxy Form27/10/09
PC1 Update - SPP Closes and HBI Featured in Lancet26/10/09
PC1 Change of Director's Interest Notice20/10/09
PC1 Letter to Shareholders - Share Purchase Plan13/10/09
PC1 Acuvax Affiliate Sales Top USD$1M in 2009PRICE SENSITIVE08/10/09
PC1 RP101 Clinical TrialsPRICE SENSITIVE06/10/09
PC1 Appendix 3B06/10/09
PC1 Annual Report to shareholders29/09/09
PC1 Share Purchase PlanPRICE SENSITIVE21/09/09
PC1 Placement and Resignation of a DirectorPRICE SENSITIVE17/09/09
PC1 Preliminary Final ReportPRICE SENSITIVE31/08/09
PC1 First Human Trials for Recombinant Dengue Fever VaccinePRICE SENSITIVE26/08/09
PC1 Acuvax Advances Technology Collaboration and Capital RaisingPRICE SENSITIVE21/08/09
PC1 Affiliate Wins Major Grant to Fight Tick Borne EncephalitisPRICE SENSITIVE12/08/09
PC1 Commitments Test Entity - Fourth Quarter ReportPRICE SENSITIVE31/07/09
PC1 Acuvax Affiliate Appoints New Director28/07/09
PC1 Market Update13/07/09
PC1 Company Presentation11/06/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE28/04/09
PC1 Acuvax Takes Cash Gain on Portion of Oncology AssetsPRICE SENSITIVE15/04/09
PC1 Acuvax Oncology Portfolio Advances in the USAPRICE SENSITIVE19/03/09
PC1 Half Yearly Report and AccountsPRICE SENSITIVE27/02/09
PC1 Hawaii Biotech Favorable Interim Results for West Nile VirusPRICE SENSITIVE26/02/09
PC1 Appendix 4C - quarterlyPRICE SENSITIVE29/01/09
PC1 Appendix 3B29/12/08
PC1 West Nile Dosing Trials Completed. Avantogen now AcuvaxPRICE SENSITIVE17/12/08
PC1 Draw Down Facility with Fortrend SecuritiesPRICE SENSITIVE03/12/08
PC1 Results of Meeting21/11/08
PC1 Non-Renounceable Issue - Offer Document
27/08/10PRICE SENSITIVE
PC1 Non-Renounceable Issue - s708AA Notice
27/08/10
PC1 Non-Renounceable Issue - Shareholder letter
27/08/10
PC1 Non-Renounceable Issue - Appendix 3B
27/08/10
PC1 s708A Notice
23/08/10PRICE SENSITIVE
PC1 Appendix 3B
23/08/10
PC1 Hawaii Biotech Inc Update
23/07/10PRICE SENSITIVE
PC1 Appointment of broker for capital raising
19/07/10
PC1 Appendix 4C - quarterly
08/07/10PRICE SENSITIVE
PC1 Business Update - HBI and Proposed Capital Raising
30/06/10PRICE SENSITIVE
PC1 Change in substantial holding
17/06/10
PC1 Change in substantial holding
09/06/10
PC1 Change of Director's Interest Notice
08/06/10
PC1 Non Renounceable Rights Issue - Allotment
04/06/10
PC1 Non Renounceable Rights Issue Result
28/05/10
PC1 Rights issue dispatch confirmation
13/05/10
PC1 Non Renounceable Rights Issue - Offer Letter
04/05/10
PC1 Non Renounceable Rights Issue - Appendix 3B
04/05/10
PC1 Non-Renounceable Rights Issue - shareholder letter
04/05/10PRICE SENSITIVE
PC1 Appendix 4C - quarterly
30/04/10PRICE SENSITIVE
PC1 Change of Director's Interest Notice x 2
25/03/10
PC1 Appendix 3B
25/03/10
PC1 Acuvax Undertakes Share Placement
23/03/10PRICE SENSITIVE
PC1 Appendix 4D and Half Year Accounts
26/02/10PRICE SENSITIVE
PC1 Appendix 4C - quarterly
28/01/10PRICE SENSITIVE
PC1 HBI Completes Phase 1 Trial
11/01/10PRICE SENSITIVE
PC1 Acuvax Affliate Receives Capital Injection
22/12/09PRICE SENSITIVE
PC1 Acuvax Affiliate Reorganises
14/12/09PRICE SENSITIVE
PC1 Results of Meeting
30/11/09
PC1 CEO's AGM Presentation
30/11/09
PC1 Chairman's Address to Shareholders
30/11/09
PC1 Initial Director's Interest Notice
27/11/09
PC1 Director Appointment/Resignation
23/11/09
PC1 Company Secretary Appointment/Resignation
10/11/09
PC1 Acuvax Requisitions Meeting of HBI Shareholders
09/11/09
PC1 Appendix 4C - quarterly
30/10/09PRICE SENSITIVE
PC1 Notice of Annual General Meeting/Proxy Form
27/10/09
PC1 Update - SPP Closes and HBI Featured in Lancet
26/10/09
PC1 Change of Director's Interest Notice
20/10/09
PC1 Letter to Shareholders - Share Purchase Plan
13/10/09
PC1 Acuvax Affiliate Sales Top USD$1M in 2009
08/10/09PRICE SENSITIVE
PC1 RP101 Clinical Trials
06/10/09PRICE SENSITIVE
PC1 Appendix 3B
06/10/09
PC1 Annual Report to shareholders
29/09/09
PC1 Share Purchase Plan
21/09/09PRICE SENSITIVE
PC1 Placement and Resignation of a Director
17/09/09PRICE SENSITIVE
PC1 Preliminary Final Report
31/08/09PRICE SENSITIVE
PC1 First Human Trials for Recombinant Dengue Fever Vaccine
26/08/09PRICE SENSITIVE
PC1 Acuvax Advances Technology Collaboration and Capital Raising
21/08/09PRICE SENSITIVE
PC1 Affiliate Wins Major Grant to Fight Tick Borne Encephalitis
12/08/09PRICE SENSITIVE
PC1 Commitments Test Entity - Fourth Quarter Report
31/07/09PRICE SENSITIVE
PC1 Acuvax Affiliate Appoints New Director
28/07/09
PC1 Market Update
13/07/09
PC1 Company Presentation
11/06/09
PC1 Appendix 4C - quarterly
28/04/09PRICE SENSITIVE
PC1 Acuvax Takes Cash Gain on Portion of Oncology Assets
15/04/09PRICE SENSITIVE
PC1 Acuvax Oncology Portfolio Advances in the USA
19/03/09PRICE SENSITIVE
PC1 Half Yearly Report and Accounts
27/02/09PRICE SENSITIVE
PC1 Hawaii Biotech Favorable Interim Results for West Nile Virus
26/02/09PRICE SENSITIVE
PC1 Appendix 4C - quarterly
29/01/09PRICE SENSITIVE
PC1 Appendix 3B
29/12/08
PC1 West Nile Dosing Trials Completed. Avantogen now Acuvax
17/12/08PRICE SENSITIVE
PC1 Draw Down Facility with Fortrend Securities
03/12/08PRICE SENSITIVE
PC1 Results of Meeting
21/11/08
refresh Created with Sketch. REFRESH
 

Top Stories

Week 47 Wrap: HotCopper users' most watched; Brent lifts on Putin's scary letter; RFK dents CSL

Welcome to the end of another week. Let's start with what HotCopper users have been watching and discussing.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
HotCopper Highlights: Your most watched stocks for Week 47, 2024 In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.